Estimation of the functions of kidney and liver in the infected COVID-19 patients
Keywords:
coronavirus disease, COVID-19, urea, creatinine, AST, ALTAbstract
Coronavirus disease 2019 (COVID-19) is one of the respiratory system diseases with unknown etiology and clinical characteristics. Defects in the liver and kidneys appear to be common in Covid-19 patients. Aspartate transaminase (AST) enzyme, Urea, creatinine, and Alanine Aminotransferase (ALT) enzyme levels are frequently exalted at the start or within the infection. This pretext suggests that Covid-19 interferes with the functions of the liver and kidneys. The current study was aimed to estimate the biochemical biomarkers changes that related to liver and kidney functions, such as ALT, AST, urea, and creatinine, in infected patients. 50 patients were diagnosed with infected between May 1 and 1 August 2020, in Dayala Hospital. 100 samples included 50 control and 50 infected were carried out to evalute the level of biochemical biomarkers (the plasma urea, creatinine, ALT and AST).The results showed increased of ALT, AST, BUN and creatinine levels in the infected samples compare with the control samples. The mean serum kidney parameter (Urea, creatinine ) levels were 57.84±10.46, 1.61±0.18respectively, while the mean value of serum liver enzyme (AST, ALT) levels were 41.94±4.59 and 42.54±4.45, respectively, with high significant different (P<0.001) with control healthy group.
Downloads
References
Zhang, C., Shi, L. and Wang, F.S., 2020. Liver injury in COVID-19: management and challenges. The lancet Gastroenterology & hepatology, 5(5), pp.428-430.
Phan, L.T., Nguyen, T.V., Luong, Q.C., Nguyen, T.V., Nguyen, H.T., Le, H.Q., Nguyen, T.T., Cao, T.M. and Pham, Q.D., 2020. Importation and human-to-human transmission of a novel coronavirus in Vietnam. New England Journal of Medicine, 382(9), pp.872-874
Wu, Z. and McGoogan, J.M., 2020. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. Jama, 323(13), pp.1239-1242..
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y. and Yu, T., 2020. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The lancet, 395(10223), pp.507-513.
Jalil, A.T., Shanshool, M.T., Dilfy, S.H., Saleh, M.M. and Suleiman, A.A., 2021. HEMATOLOGICAL AND SEROLOGICAL PARAMETERS FOR DETECTION OF COVID-19. Journal of microbiology, biotechnology and food sciences, pp.e4229-e4229.
Rismanbaf, A. and Zarei, S., 2020. Liver and kidney injuries in COVID-19 and their effects on drug therapy; a letter to editor. Archives of academic emergency medicine, 8(1), pp.e17-e17.
Mantovani, A., Beatrice, G. and Dalbeni, A., 2020. Coronavirus disease 2019 and prevalence of chronic liver disease: A meta‐analysis. Liver international, 40(6), pp.1316-1320.
Cheng, Y., Luo, R., Wang, K., Zhang, M., Wang, Z., Dong, L., Li, J., Yao, Y., Ge, S. and Xu, G., 2020. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney international, 97(5), pp.829-838.
Aronson, D., Mittleman, M.A. and Burger, A.J., 2004. Elevated blood urea nitrogen level as a predictor of mortality in patients admitted for decompensated heart failure. The American journal of medicine, 116(7), pp.466-473.
Ito, A., Ishida, T., Tokumasu, H., Washio, Y., Yamazaki, A., Ito, Y. and Tachibana, H., 2017. Prognostic factors in hospitalized community-acquired pneumonia: a retrospective study of a prospective observational cohort. BMC pulmonary medicine, 17(1), pp.1-10.
Ugajin, M., Yamaki, K., Iwamura, N., Yagi, T. and Asano, T., 2012. Blood urea nitrogen to serum albumin ratio independently predicts mortality and severity of community-acquired pneumonia. International journal of general medicine, 5, p.583.
Feng, D.Y., Zhou, Y.Q., Zou, X.L., Zhou, M., Yang, H.L., Chen, X.X. and Zhang, T.T., 2019. Elevated blood urea nitrogen-to-serum albumin ratio as a factor that negatively affects the mortality of patients with hospital-acquired pneumonia. Canadian Journal of Infectious Diseases and Medical Microbiology, 2019
Haines, R.W., Zolfaghari, P., Wan, Y., Pearse, R.M., Puthucheary, Z. and Prowle, J.R., 2019. Elevated urea-to-creatinine ratio provides a biochemical signature of muscle catabolism and persistent critical illness after major trauma. Intensive care medicine, 45(12), pp.1718-1731.
Sujino, Y., Nakano, S., Tanno, J., Shiraishi, Y., Goda, A., Mizuno, A., Nagatomo, Y., Kohno, T., Muramatsu, T., Nishimura, S. and Kohsaka, S., 2019. Clinical implications of the blood urea nitrogen/creatinine ratio in heart failure and their association with haemoconcentration. ESC heart failure, 6(6), pp.1274-1282.
Gupta, A., Madhavan, M.V., Sehgal, K., Nair, N., Mahajan, S., Sehrawat, T.S., Bikdeli, B., Ahluwalia, N., Ausiello, J.C., Wan, E.Y. and Freedberg, D.E., 2020. Extrapulmonary manifestations of COVID-19. Nature medicine, 26(7), pp.1017-1032.
Zhou, P., Yang, X.L., Wang, X.G., Hu, B., Zhang, L., Zhang, W., Si, H.R., Zhu, Y., Li, B., Huang, C.L. and Chen, H.D., 2020. A pneumonia outbreak associated with a new coronavirus of probable bat origin. nature, 579(7798), pp.270-273.
Gorbalenya, A.E., Baker, S.C., Baric, R., Groot, R.J.D., Drosten, C., Gulyaeva, A.A., Haagmans, B.L., Lauber, C., Leontovich, A.M., Neuman, B.W. and Penzar, D., 2020. Severe acute respiratory syndrome-related coronavirus: The species and its viruses–a statement of the Coronavirus Study Group.
Lin, W., Hu, L., Zhang, Y., Ooi, J.D., Meng, T., Jin, P., Ding, X., Peng, L., Song, L., Xiao, Z. and Ao, X., 2020. Single-cell analysis of ACE2 expression in human kidneys and bladders reveals a potential route of 2019-nCoV infection. BioRxiv.
Fan, C., Li, K., Ding, Y., Lu, W.L. and Wang, J., 2020. ACE2 expression in kidney and testis may cause kidney and testis damage after 2019-nCoV infection. MedRxiv.
Wang, L., Li, X., Chen, H., Yan, S., Li, D., Li, Y. and Gong, Z., 2020. Coronavirus disease 19 infection does not result in acute kidney injury: an analysis of 116 hospitalized patients from Wuhan, China. American journal of nephrology, 51(5), pp.343-348.
Cheng, Y., Luo, R., Wang, K., Zhang, M., Wang, Z., Dong, L., Li, J., Yao, Y., Ge, S. and Xu, G., 2020. Kidney impairment is associated with in-hospital death of COVID-19 patients. MedRxiv.
Diao, B., Feng, Z., Wang, C., Wang, H., Liu, L., Wang, C., Wang, R., Liu, Y., Liu, Y., Wang, G. and Yuan, Z., 2020. Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. MedRxiv.
Yao, X.H., Li, T.Y., He, Z.C., Ping, Y.F., Liu, H.W., Yu, S.C., Mou, H.M., Wang, L.H., Zhang, H.R., Fu, W.J. and Luo, T., 2020. A pathological report of three COVID-19 cases by minimally invasive autopsies. Zhonghua bing li xue za zhi= Chinese journal of pathology, 49, pp.E009-E009.
Chen, X., Zhao, B., Qu, Y., Chen, Y., Xiong, J., Feng, Y., Men, D., Huang, Q., Liu, Y., Yang, B. and Ding, J., 2020. Detectable serum SARS-CoV-2 viral load (RNAaemia) is closely correlated with drastically elevated interleukin 6 (IL-6) level in critically ill COVID-19 patients. Clinical infectious diseases.
Liu, Y.F., Zhang, Z., Pan, X.L., Xing, G.L., Zhang, Y., Liu, Z.S. and Tu, S.H., 2021. The chronic kidney disease and acute kidney injury involvement in COVID-19 pandemic: A systematic review and meta-analysis. PloS one, 16(1), p.e0244779.
Ronco, C. and Reis, T., 2020. Kidney involvement in COVID-19 and rationale for extracorporeal therapies. Nature Reviews Nephrology, 16(6), pp.308-310.
Dai, N. and Chen, H., 2017. Mechanical ventilation and acute kidney disease. Chin J Kidney Dis Invest (Electrionic Edition), 6(04), pp.186-9.
Jothimani, D., Venugopal, R., Abedin, M.F., Kaliamoorthy, I. and Rela, M., 2020. COVID-19 and the liver. Journal of hepatology, 73(5), pp.1231-1240.
Schaefer, E.A., Arvind, A., Bloom, P.P. and Chung, R.T., 2020. Interrelationship between coronavirus infection and liver disease. Clinical Liver Disease, 15(5), p.175.
Mantovani, A., Beatrice, G. and Dalbeni, A., 2020. Coronavirus disease 2019 and prevalence of chronic liver disease: A meta‐analysis. Liver international, 40(6), pp.1316-1320.
Gori, A., Dondossola, D., Antonelli, B., Mangioni, D., Alagna, L., Reggiani, P., Bandera, A. and Rossi, G., 2020. Coronavirus disease 2019 and transplantation: a view from the inside. American Journal of Transplantation, 20(7), pp.1939-1940.
Yip, T.C.F., Lui, G.C.Y., Wong, V.W.S., Chow, V.C.Y., Ho, T.H.Y., Li, T.C.M., Tse, Y.K., Hui, D.S.C., Chan, H.L.Y. and Wong, G.L.H., 2021. Liver injury is independently associated with adverse clinical outcomes in patients with COVID-19. Gut, 70(4), pp.733-742.
Saini, R.K., Saini, N., Ram, S., Soni, S.L., Suri, V., Malhotra, P., Kaur, J., Verma, I., Sharma, S. and Zohmangaihi, D., 2020. COVID-19 associated variations in liver function parameters: a retrospective study. Postgraduate Medical Journal.
Singh, S. and Khan, A., 2020. Clinical characteristics and outcomes of coronavirus disease 2019 among patients with preexisting liver disease in the United States: a multicenter research network study. Gastroenterology, 159(2), pp.768-771.
Gori, A., Dondossola, D., Antonelli, B., Mangioni, D., Alagna, L., Reggiani, P., Bandera, A. and Rossi, G., 2020. Coronavirus disease 2019 and transplantation: a view from the inside. American Journal of Transplantation, 20(7), pp.1939-1940.
Ansari, M.J., Jasim, S.A., Taban, T.Z. et al. (2022). Anticancer Drug-Loading Capacity of Green Synthesized Porous Magnetic Iron Nanocarrier and Cytotoxic Effects Against Human Cancer Cell Line. J Clust Sci. https://doi.org/10.1007/s10876-022-02235-4
Dmitry Olegovich Bokov, Abduladheem Turki Jalil, Forat H. Alsultany, Mustafa Z. Mahmoud, Wanich Suksatan, Supat Chupradit, Maytham T. Qasim & Parvaneh Delir Kheirollahi Nezhad (2022) Ir-decorated gallium nitride nanotubes as a chemical sensor for recognition of mesalamine drug: a DFT study, Molecular Simulation, DOI: 10.1080/08927022.2021.2025234
Huldani, H., Jasim, S. A., Bokov, D. O., Abdelbasset, W. K., Shalaby, M. N., Thangavelu, L., ... & Qasim, M. T. (2022). Application of extracellular vesicles derived from mesenchymal stem cells as potential therapeutic tools in autoimmune and rheumatic diseases. International Immunopharmacology, 106, 108634.
Zainab I. Mohammed and Maytham T. Qasim (2021) Hormonal profile of men during infertility. Biochem. Cell.Arch.21, 2895-2898. DocID: https://connectjournals.com/03896.2021.21.2895
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
